RYSPX Performance — S&P 500 Fund, Class H
Data updated: 2026-08-28
RYSPX returned +9.30% year to date and +20.31% over one year to Jun 2026. Annualised returns are +18.62% over 3 years and +11.53% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $167, against $157 for the category, and to $120 over one year, against $118. Volatility over the past three years was 12.99% a year. In the 12 months to Jun 2026 the fund lost a net $48.7M, and assets reached $155.25M.
RYSPX Growth of $100
What $100 invested in S&P 500 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | RYSPX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $120 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $167 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $173 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $252 | $229 |
RYSPX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.30% |
| 1 year | +20.31% |
| 3 years (annualised) | +18.62% |
| 5 years (annualised) | +11.53% |
RYSPX Annual Returns
Calendar-year total returns of S&P 500 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +9.30% |
| 2025 | +15.93% |
| 2024 | +22.99% |
| 2023 | +24.16% |
| 2022 | −19.48% |
| 2021 | +26.67% |
| 2020 | +16.27% |
| 2019 (Jul–Dec) | +9.88% |
RYSPX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.3% | −0.9% | −5.0% | +10.2% | +5.1% | −1.1% | — | — | — | — | — | — |
| 2025 | +2.6% | −1.4% | −5.8% | −0.8% | +6.1% | +5.0% | +2.1% | +1.9% | +3.5% | +2.2% | +0.1% | −0.1% |
| 2024 | +1.5% | +5.2% | +3.1% | −4.2% | +4.8% | +3.5% | +1.1% | +2.3% | +2.0% | −1.1% | +5.7% | −2.5% |
| 2023 | +6.1% | −2.6% | +3.5% | +1.4% | +0.3% | +6.5% | +3.1% | −1.7% | −4.9% | −2.2% | +9.0% | +4.4% |
| 2022 | −5.3% | −3.1% | +3.6% | −8.9% | +0.1% | −8.4% | +9.1% | −4.2% | −9.4% | +8.0% | +5.4% | −5.9% |
| 2021 | −1.1% | +2.6% | +4.2% | +5.2% | +0.6% | +2.2% | +2.2% | +2.9% | −4.8% | +6.9% | −0.8% | +4.3% |
| 2020 | −0.2% | −8.4% | −12.5% | +12.6% | +4.6% | +1.8% | +5.5% | +7.0% | −3.9% | −2.8% | +10.8% | +3.7% |
| 2019 | — | — | — | — | — | — | +1.3% | −1.7% | +1.7% | +2.0% | +3.5% | +2.8% |
RYSPX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.99%
- 3-year Sharpe ratio: 1.09 (vs 4.5% risk-free rate)
- Best month: +10.20% (Apr 2026)
- Worst month: −5.78% (Mar 2025)
RYSPX Fund Flows
Monthly money in and out of S&P 500 Fund, from SEC Form N-PORT.
- 12-month net flow: −$48.7M
- 12-month gross sales (incl. reinvestments): $585.6M
- Sales ÷ redemptions: 0.92×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $17.5M | $55.4M | −$37.8M |
| May 2026 | $63.0M | $57.8M | $5.2M |
| Apr 2026 | $43.5M | $19.3M | $24.2M |
| Mar 2026 | $23.3M | $33.6M | −$10.3M |
| Feb 2026 | $53.3M | $61.5M | −$8.2M |
| Jan 2026 | $42.6M | $47.3M | −$4.7M |
| Dec 2025 | $86.4M | $36.9M | $49.4M |
| Nov 2025 | $88.5M | $131.1M | −$42.6M |
| Oct 2025 | $23.2M | $24.7M | −$1.5M |
| Sep 2025 | $29.1M | $34.3M | −$5.2M |
| Aug 2025 | $90.0M | $90.2M | −$226K |
| Jul 2025 | $25.1M | $42.1M | −$17.0M |
RYSPX Assets Under Management
Net assets of S&P 500 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $155.25M |
| 2026-03-31 | $139.23M |
| 2025-12-31 | $169.47M |
| 2025-09-30 | $165.20M |
| 2025-06-30 | $174.84M |
| 2025-03-31 | $178.60M |
| 2024-12-31 | $239.26M |
| 2024-09-30 | $254.43M |
| 2024-06-30 | $239.43M |
| 2024-03-31 | $214.03M |
| 2023-12-31 | $182.07M |
| 2023-09-30 | $143.46M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.